Patel Snehal 4
4 · Greenwich LifeSciences, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
- Purchase
Common Stock
2025-01-07$13.75/sh+1,800$24,750→ 5,550,002 total - Purchase
Common Stock
2025-01-06$13.31/sh+1,100$14,641→ 5,548,202 total